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The electrocardiogram (ECG) represents the difference in electrical potential between a point on the body surface and an indifferent electrode, or between pairs of points; it provides a recording of the electrical activity of the heart in the vector of the lead chosen. It is assumed that the reader is familiar with the usual nomenclature and range of lead configurations. The ECG in recording the mass electrical potential of the heart may be used as a rate meter, to detect dysrhythmias, to detect myocardial ischaemia or injury, and as an additional monitor to have in place if problems are anticipated.
Heart rate meter
The ECG may be used as a heart rate meter in healthy patients in whom no problems are anticipated. However, the ECG gives no indication of the adequacy of the circulation, and does not, on its own, constitute an adequate continuous monitor of the circulation. Baroreceptor and chemoreceptor function may both be severely impaired under anaesthesia, and a regular, unchanged trace is no guarantee that the patient is not profoundly hypoxic, hypotensive, or hypercarbic. I ,2 Betablockade diminishes the rate changes with these stresses and further limits the value of the ECG as a non-specific warning device.
As a simple monitoring device the tissue plethysmograph (pulse meter) gives better and more relevant information; better because the signal is impervious to diathermy, and more relevant, as a pulse guarantees some circulation. A pulse meter also does not degrade the natural skin resistance, does not require disposable electrodes, and does not require a high degree of electrical isolation.
Dysrhythmias
The ECG may be used to detect and characterise disturbances of cardiac rhythm and conduction. Standard Lead II is usually the best lead, as its vector is parallel to the net depolarisation vector of the atrial wave, and hence usually shows the P wave best. An ECG should be used in any patient on antiarrhythmic agents or in whom dysrhythmias are anticipated. For routine anaesthesia in healthy young patients, a pulse monitor or stethoscope will detect the presence of any dysrhythmias, and then an ECG monitor may be used to define the type, if necessary. Specific drug treatment for dysrhythmias is very rarely indicated, as they are usually evanescent and seldom cause significant impairment of the cardiac output.
Myocardial ischaemia
The ECG is widely used for detecting myocardial ischaemia, but unfortunately suffers from poor sensitivity and specificity. Changes in the ST segment of the ECG may be produced by factors other than ischaemia, and some patients with myocardial ischaemia do not have ECG changes. With the use of lead V5 in the cardiology environment it has been claimed that about 90% of ST segment and T wave changes are detected. 3 However, this appears to be optimistic in the anaesthetic setting. Ischaemia may occur with no ECG changes. Smith and co-workers in 1985 examined fifty 'at-risk' patients by transoesophageal echocardiography and ECG during their operation. 4 Twenty-four showed segmental wall abnormalities but only six had ECG changes. Three patients with abnormal wall motion developed perioperative myocardial infarction but only one of these had ST segment changes.
Leads V4 and V5 are anatomically close to the normal left ventricle and are useful for monitoring anterior wall ischaemia; this region is supplied by the left main, left anterior descending, or circumflex coronary artery. Leads 11, III and A VF view the heart inferiorly and display the electrical activity of the area of myocardium supplied mainly by the right coronary artery. Some areas of the heart are difficult to monitor. Right ventricular dysfunction associated with inferior ischaemia is difficult to detect using standard leads and is probably best observed by a V 4R lead (4th intercostal space in the right midclavicular line). 5 Posterior ischaemia is even more difficult to monitor using surface leads and the only sign may be slight ST segment depression in lead VI. Posterior ischaemia may be monitored with an oesophageal lead which also produces a good P wave deflection.
Most ECG monitors provide only a three-lead system, and many modifications have been suggested to improve their ability to detect myocardial ischaemia. Only a few need to be considered. These three-lead configurations are more convenient than five-lead systems but are not as informative. 6 Modified V5 (the left arm lead in the V5 position) can be used to detect antero-Iateral wall ischaemia with the monitor on the Lead I setting, or to detect inferior wall ischaemia with the monitor on the Lead 11 setting. CM5 (left arm lead in the V5 position, right arm lead on the right sternal border, and the leg lead on the left shoulder) is the most comprehensive method to monitor ischaemia using three leads as it detects ST segment changes more frequently than other three-lead configurations.
If ischaemic changes are to be detected in patients undergoing anaesthesia, a paper recording is essential to allow adequate calibration of the trace and to allow accurate measurements to be taken from the trace. The 'diagnostic mode' must be used (see below). With a standard ImV equal to 10 mm, changes of 1 mm (O.lmV) or greater in an ST segment indicate ischaemia until proven otherwise. Such a small change is very difficult to see on a monitor screen. The paper trace also provides a permanent record of the trace of the voltage calibration. Hz. Monitor mode, for which there is no specification, is usually a narrower bandwith, generally 0.4-40 Hz with a sharp attenuation or a 50 Hz notch filter. Elevation of the lower frequency response in the monitor mode reduces the baseline drift which sometimes occurs with respiration. However, the loss of the very slow frequencies may obscure ST or T wave changes. Reduction of the upper frequency limit attenuates the artifacts of muscle tremors, movement and shivering, but it may introduce widening of the QRS complex.
When to use an ECG monitor
In 1984 the Australasian Faculty of Anaesthetists specified that a pulse or ECG monitor should be available in each operating theatre, and that an ECG monitor should be available in all operating suites. 9 Thus, an ECG monitor has to be available, but its use on every patient is not required.
Some anaesthetists routinely use an ECG monitor on every patient; this practice has been recommended in the United Kingdom 10 . 11 and is now a requirement in the United States. 12 ,13 However, there was agreement at the Adelaide 1987 meeting on 'Monitoring and Patient Safety' that with a requirement for the use of an ECG monitor on every healthy child and young adult, the disadvantages may outweigh the slender advantages.
Firstly, there is some risk of the ECG providing a false sense of security; as indicated above, an unchanged ECG is no guarantee that the patient is not aware, hypoxic, hypercarbic or hypotensive. ECG monitoring does not release the anaesthetist from the responsibility of continuously monitoring the circulation: a finger on the pulse, continuous auscultation via an oesophageal or precordial stethoscope or the use of an audible pulse meter or pulse oximeter is required in any event.
Secondly, savings on disposable ECG electrodes could be put towards the purchase of other monitors. ECG electrodes consume more funds than any other disposable items in many departments of anaesthesia, including endotracheal tubes (R. Holland, personal communication 1987).
Thirdly, although ECG monitors are often used ostensibly to detect ischaemia, they are frequently used in a manner unlikely to achieve this. Selection of a suitable machine, correct placement of electrodes, selection of the correct 'mode' and lead, accurate calibration and a paper trace are all necessary, and should all be part of the preanaesthetic equipment check if one wishes to monitor for ischaemia. A pilot study has revealed that in many institutions in which ECG monitors are routinely used, the manner in which they are used guarantees that only a very small fraction of ischaemic events will be detected. Frequently, the leads in which ST segment changes were evident preoperatively, are not selected during anaesthesia and postoperatively. If the anaesthetist has to consider why, how and when the ECG should be monitored, then ECG monitoring may become more fruitful.
It is .suggested that an audible pulse meter, stethoscope or pulse oximeter be used on healthy patients under 35 years of age, who have no risk factors, and that ECG monitoring is not necessary in this group. Epstein and Maron suggested that 200,000 athletes under 35 years would have to be examined to find just one who may die during strenuous exercise. 14 On the other hand, the incidence of coronary atheroma and sudden death does increase after this age, and the risk of myocardial ischaemia and sudden death is increased two or three fold if factors such as family history, smoking, hypertension and hypercholesterolaemia are added. 14 For some patients, the fear of awareness or of 'waking up in the middle of the operation' is greater than concern about the impending surgery. Likewise, for most anaesthetists a major concern after ensuring that the patient comes to no harm, is that the patient is not 'aware'. Despite the tremendous advances that have been made in anaesthesia, we are still unable to predict reliably whether our patient will be asleep throughout the anaesthetic; indeed, endeavours to find a single parameter that truly represents depth of anaesthesia have been compared with those of the alchemists in their search for the philosopher's stone. l Awareness is a problem in about 2% of all anaesthetics administered;2 there were 55 cases of awareness reported to the Medical Defence Union out of 150 I untoward anaesthesia-related events. 3 Awareness had a greater incidence than extravasation of drugs, pneumothoraces, burns, minor injuries and inhalation of foreign bodies. Moreover, its incidence has not declined in recent years. 3 This is due, at least in part, to the modern practice of using several drugs in combination with muscle relaxants. For patients breathing spontaneously, Guedel's classification provides some guide to the level of anaesthesia. l Awareness in apparently adequately anaesthetised patients breathing a volatile agent spontaneously is rare, but has been documented. 4 However, seven of the nine components of Guedel's system involve skeletal muscle activity and when muscle relaxants are used only pupil size and lacrimation are left. The signs which most anaesthetists now have to rely on are these and others mediated by the autonomic nervous system (sweating and an increase in heart rate and blood pressure). Unfortunately, these are unreliable indicators of depth of anaesthesia and awareness. The problem is aggravated by the use of potent analgesics which are poor hypnotics, by great inter-individual variability in responses to drugs, 5 and by the fact that many drugs may be used which themselves interfere with autonomic responses (e.g. opioids, phenothiazines, adrenergic blockers, anticholinergics). As these signs are so unsatisfactory, the modern anaesthetist generally has to rely on giving a little more anaesthetic, rather than a little less. When combinations of drugs are being used, the anaesthetist has to rely on experience and on a knowledge of the properties of the drugs being used to gauge the correct level of anaesthesia for each patient, assisted by the limited signs available.
Given this unsatisfactory situation, and given our poor understanding of the central nervous system in general, and of awareness and consciousness in particular, it is not surprising that awareness still occurs. In spite of great research effort in this area, there is currently no device which is generally accepted as providing a reliable indication of depth of anaesthesia. An ideal 'depth of anaesthesia monitor' should be reliable, and simple to set up, use and interpret, but should not be 'agent-specific' or present increased risk to the patient.
Attempts have been made to use the electroencephalogram (EEG). The EEG has not gained acceptance because it is logistically difficult to use, the traces are difficult to interpret, and there are differences between the traces obtained with
